Bluejay Diagnostics (BJDX) Assets Average (2021 - 2026)
Bluejay Diagnostics (BJDX) reported Assets Average of $6.4 million for Q1 2026, up 6.56% on a YoY basis from $6.0 million in Q1 2025, and up 5.9% sequentially from $6.0 million in Q4 2025.
Bluejay Diagnostics (BJDX) Assets Average (2021 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 6 years of Assets Average data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 6.56% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 6.56% YoY), and the FY2025 full-year result was $6.9 million, up 19.53% from the prior year.
- Assets Average grew to $6.4 million in Q1 2026, from $6.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $20.5 million in Q1 2022 to a low of $5.0 million in Q1 2024.
- A 5-year average of $9.9 million and a median of $8.0 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slumped 59.26% in 2024 and advanced 20.03% in 2025, its largest moves.
- Tracing BJDX's Assets Average over 5 years: stood at $14.6 million in 2022, then sank by 55.13% to $6.6 million in 2023, then grew by 14.45% to $7.5 million in 2024, then dropped by 19.99% to $6.0 million in 2025, then gained by 5.9% to $6.4 million in 2026.
- Business Quant data shows BJDX's Assets Average at $6.4 million in Q1 2026, $6.0 million in Q4 2025, and $5.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 6.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 5.65 Mn |
| Jun 30, 2025 | 5.84 Mn |
| Mar 31, 2025 | 5.97 Mn |
| Dec 31, 2024 | 7.51 Mn |
| Sep 30, 2024 | 9.61 Mn |
| Jun 30, 2024 | 7.97 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 6.56 Mn |
| Sep 30, 2023 | 8.36 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 12.20 Mn |
| Dec 31, 2022 | 14.61 Mn |
| Sep 30, 2022 | 16.89 Mn |
| Jun 30, 2022 | 19.07 Mn |
| Mar 31, 2022 | 20.55 Mn |
| Dec 31, 2021 | 12.32 Mn |